Table 1 Patient characteristics
From: Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
Total | AF | SR | p | |
|---|---|---|---|---|
n | 170 | 14 | 156 | |
m/f | 65/105 | 5/9 | 60/96 | 0.8394 |
AD/aMCI (n, AD%) | 115/55 (67.6%) | 13/1 (92.9%) | 102/54 (65.4%) | 0.0382 |
MMSE-J score (ave. ± SD) | 21.8 ± 4.3 | 22.0 ± 4.4 | 19.4 ± 3.1 | 0.0347 |
Age (ave. ± SD, y.o.) | 79.5 ± 7.4 | 81.6 ± 4.1 | 79.3 ± 7.6 | 0.2575 |
Hypertension (%) | 65.9 | 71.4 | 65.4 | 0.6477 |
Dyslipidemia (%) | 37.7 | 28.6 | 38.5 | 0.4644 |
Diabetes mellitus (%) | 25.9 | 50.0 | 23.7 | 0.0315 |
Dysthyroidism (%) | 4.7 | 0.0 | 5.2 | 0.3838 |
CTR (ave. ± SD, %) | 50.7 ± 5.8 | 57.6 ± 5.9 | 50.0 ± 5.6 | 0.0347 |
Systolic BP (ave. ± SD, mmHg) | 139.3 ± 22.1 | 146.6 ± 35.5 | 137.1 ± 21.6 | 0.1384 |
Diastolic BP (ave. ± SD, mmHg) | 74.0 ± 13.2 | 74.9 ± 18.8 | 73.2 ± 12.8 | 0.6361 |
eGFR (ave. ± SD, ml/min/1.73 m2) | 68.4 ± 19.7 | 65.4 ± 17.8 | 68.3 ± 20.0 | 0.5965 |
Hemoglobin (ave. ± SD, mg/dL) | 12.8 ± 1.8 | 13.3 ± 1.5 | 12.8 ± 1.8 | 0.3171 |
WBC (ave. ± SD, /μL) | 5918 ± 1517.2 | 6079 ± 1911.6 | 5801 ± 1541.4 | 0.5284 |
CRP (ave. ± SD, mg/dL) | 0.181 ± 0.409 | 0.229 ± 0.388 | 0.175 ± 0.407 | 0.6453 |
Homocysteine (ave. ± SD, mg/dL) | 14.1 ± 10.0 | 13.4 ± 5.8 | 14.1 ± 10.5 | 0.8092 |
Vitamin B12 (ave. ± SD, mg/dL) | 620.1 ± 810.4 | 785.2 ± 695.9 | 605.6 ± 806.5 | 0.4380 |
Folic acid (ave. ± SD, mg/dL) | 9.8 ± 5.3 | 10.3 ± 6.2 | 9.7 ± 5.1 | 0.6952 |